- Research
- Open access
- Published:
Refining a hybrid music therapy intervention for chronic obstructive pulmonary disease and heart failure: a single arm pilot study
BMC Complementary Medicine and Therapies volume 25, Article number: 139 (2025)
Abstract
Background
Chronic obstructive pulmonary disease (COPD) and heart failure (HF) pose significant challenges to patients and the health systems that care for them. Music therapy has the potential to address these challenges, but its impact on readmission rates and quality of life remains largely underexplored. This study evaluated the feasibility, fidelity, and acceptability of a hybrid music therapy intervention as a precursor to a randomized controlled trial (RCT).
Methods
Using a single-arm, mixed-methods approach, inpatients aged 30 - 89 with COPD or HF and access to home videoconferencing technology, a mobile device with a data plan, and a reliable support person were recruited during their hospitalizations. Patients with significant hearing/visual impairments, severe psychological comorbidities, terminal medical conditions, stage IV HF, or end-stage COPD were excluded. The intervention included 2 inpatient in-person sessions and 2 virtual sessions following discharge. Feasibility was assessed by rates of recruitment, retention, session attendance, and measure completion. Fidelity was evaluated by adherence to the session protocol, while acceptability was assessed through semi-structured interviews with randomly selected participants.
Results
Of 113 patients approached, 20 (17.7%) were enrolled, and 85% were retained. Median participant age was 61.5 years, with 80% having HF and participants having high rates of anxiety (50%) and depression (35%). Overall session attendance was 57.5%, with higher rates for in-person (75%) compared to virtual sessions (40%). Adherence to the intervention protocol was > 80% across all monitored sessions. Challenges with the trial included difficulty reaching participants following discharge, frequent virtual session rescheduling, and participants’ challenges using technology. Semi-structured interviews supported the acceptability of the intervention with three emerging themes (1) the therapeutic relationship facilitated a positive intervention experience, (2) need for strategies to improve post-discharge engagement in the intervention, and (3) impacts on mental health.
Conclusions
Findings support the feasibility of hybrid music therapy among patients with COPD or HF. However, challenges in post-discharge communication and virtual session attendance were noted. These issues will be addressed in a subsequent feasibility RCT through implementing secure text-based communication in addition to phone communication to reach participants post-discharge, refined eligibility criteria (e.g., excluding patients on dialysis), and in-person technology instruction.
Trial registration
ClinicalTrials.gov NCT06214325. Registered on January 9, 2024.
Introduction
Chronic diseases such as chronic obstructive pulmonary disease (COPD) and heart failure (HF) pose significant challenges to individuals living with these conditions and the health systems that care for them. Globally, HF is estimated to affect 64.3 million people, including 1.7% of individuals across 13 European countries, and is the leading cause of hospitalizations among patients aged 65 and older [1]. Despite improvements in treatment for individuals with HF, hospital readmission rates remain high among this population where more than 1 million are hospitalized each year in the United States (US) [2]. Similarly, COPD affects approximately 391.9 million people around the world with an estimated prevalence of 10.3% among individuals 30–79 years old according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) case definition [3]. In the US, COPD affects over 12 million adults and is the third leading cause of 30-day readmissions [4].
Costs related to caring for these populations are substantial. A systematic review of 16 international studies estimated overall lifetime health care costs to be $126,819 per patient with HF [5]. Another review of studies from 197 counties estimated that the overall economic costs of HF in 2012 were $108 billion per year, with high spending variability between high-income and middle and low-income countries [6]. The prevalence of HF in the US is predicted to increase by 46% from 2012 to 2030 with an associated increase in costs of $390 billion [7], while hospitalizations for COPD exacerbation account for $13.2 billion of the nearly $50 billion annual direct costs for COPD in the US [8]. In addition to the direct cost of hospitalization, healthcare systems must also manage financial penalties issued from Medicare’s Hospital Readmissions Reduction Program (HRRP). The HRRP states that if a hospital’s readmission rate for diagnoses including COPD and HF exceeds the national average by a predetermined percentage, the hospital will be penalized with reductions in reimbursement from the Centers for Medicare and Medicaid Services, the US federal agency that provides health coverage for individuals aged 65 and older, persons with disabilities, and people with low socioeconomic status (SES) [9].
Mental health conditions and self-reported symptoms of depression and anxiety are prevalent among individuals with COPD and HF and significant risk factors for readmission [10] and impaired health-related quality of life (HRQoL) [7, 11]. Patients hospitalized for physical health conditions who have mental health comorbidities have been found to be 28% more likely to be readmitted compared to those without mental illness [10]. Among patients with COPD, psychological comorbidities are associated with lower reports of self-efficacy, more frequent and longer hospital readmissions, and reduced survival [12]. Previous research supports the effectiveness of mental health and multidisciplinary interventions for improving mental health and reducing readmission rates within this population [10, 13]. However, barriers such as limited mobility, lack of transportation access, financial barriers, time constraints, and stigma concerns may prevent individuals with HF or COPD from accessing these interventions [14]. To improve access, some providers have developed virtual forms of care, and recent studies support the feasibility of virtual interventions such as pulmonary rehabilitation [15, 16].
One intervention that has potential to address the mental health risk factors that contribute to readmission risk is music therapy, defined as the clinical and evidence-based use of music interventions to accomplish individualized goals within a therapeutic relationship by a credentialed professional who has completed an approved music therapy program [17]. Meta-analyses have demonstrated music therapy’s efficacy for addressing psychosocial risk factors for readmission including stress [18], pain [19], anxiety [20], and depression among older adults [21]. Previous music therapy studies among patients with COPD have demonstrated its benefits for acute symptom management, improving pulmonary functioning outcomes [22, 23], and building a sense of community when delivered in a group setting. Among patients with HF, prior work has investigated the mechanisms by which music engagement can positively influence mental wellbeing and cardiovascular measures via increasing parasympathetic activation [24].
Furthermore, from a mechanistic standpoint, music interventions have demonstrated efficacy within randomized controlled trials (RCTs) for not only reducing perceived stress [18], but also decreasing serum cortisol (an important biomarker for stress and inflammation) among hospitalized patients [25]. Given that psychological stress is a modifiable risk factor associated with higher risk for readmission among patients with HF [26] and patients with COPD [27], music therapy may further reduce readmission risk by reducing both physiological and psychological stress. Given the increasing integration of music therapists within hospitals [28, 29], music therapy may have unique advantages compared to other mental health interventions (e.g., cognitive behavioral therapy delivered by a psychologist) which may not be as readily available within US hospitals.
However, few studies have investigated psychosocial outcomes of music therapy interventions specifically among people with COPD and HF. Only two music therapy studies have examined readmissions as an outcome to date [30, 31], and no studies have examined the impact of music therapy on readmission among patients with HF or COPD. In addition to a lack of research on readmission outcomes within music therapy, there remain gaps in understanding (1) longitudinal effects on critically important outcomes such as HRQoL and self-efficacy; (2) the feasibility and acceptability of virtual care models; and (3) fidelity when delivering multiple manualized interventions. The few studies that exist on these topics have been conducted among adults with chronic pain and support music therapy’s feasibility, acceptability, and preliminary efficacy for addressing HRQoL and improving self-efficacy [32,33,34] as well as the feasibility of a virtual care model [35].
Therefore, given the (1) psychosocial factors driving risk for 30-day admission; (2) demonstrated efficacy of music therapy for addressing these factors within other populations [18,19,20]; (3) lack of music therapy studies investigating 30-day readmission and HRQoL; and (4) critical importance for hospitals to reduce 30-day readmission rates for adults with chronic illness, a two-year research project entitled Music therapy to Address patients' JOuRneys with CHronic illness, Outcomes, and ReaDmission (MAJOR CHORD) was launched to address this major gap in music therapy research and begin the process of investigating whether music therapy could address HRQoL and readmission risk among people with COPD or HF. Prior to examining music therapy’s efficacy with a fully powered RCT, the study team recognized the need to perform a feasibility RCT [36]. However, given the novelty of conducting a hybrid music therapy intervention and the anticipated challenges of collecting follow-up data with this population, a single-arm pilot was initiated as a first step to allow the study team to quickly uncover and generate solutions to intervention and data collection challenges prior to devoting more resources to a feasibility RCT with a comparison arm. Thus, the purpose of this study was to (1) examine the feasibility, fidelity, and acceptability of the music therapy intervention and collection of patient-reported outcome measures (PROMs) through 30 days after hospital discharge and (2) determine which modifications (if any) would need to be made to the intervention and data collection processes prior to initiating a feasibility RCT.
Methods
Design
This study utilized a mixed-methods intervention design in which qualitative data were embedded within the framework of a single-arm trial [37]. A mixed-methods intervention design was chosen to enhance understanding of participants’ mental health, experience with the music therapy exercises, and perceived acceptability of the music therapy intervention. This qualitative data was also used to provide context for any potential changes that would need to be made to intervention delivery and data collection procedures prior to conducting a feasibility RCT. Per guidance from the National Center for Complementary and Integrative Health (NCCIH) [36], the sample size (N = 20) was primarily based on how many participants could practically be recruited, provided music therapy interventions, and evaluated for future intervention and data collection refinements in the feasibility RCT given the time and budget allotted within the grant. Sample size determination was also informed by prior music therapy feasibility studies among patients with sickle cell disease (N = 12 in intervention arm) [32], patients with chronic pain (N = 22 in intervention arm) [34], and adolescent and young adults undergoing stem-cell transplant (N = 7 in intervention arm) [38].
Participants
This study was conducted between January 2024 and April 2024 at University Hospitals Cleveland Medical Center, a large Midwestern hospital in the United States. Subjects who (1) were aged 30 to 89; (2) had a diagnosis (primary or secondary) of either COPD or HF documented within the electronic health record (EHR); (3) were anticipated to remain hospitalized for ≥ 2 days following recruitment; (4) were able to read and understand English; (5) had access to Wi-Fi, a video conferencing device (i.e. laptop, tablet, and/or PC), and an active email address; (6) had a mobile device with an active data plan; and (7) had a reliable support person who could be available to respond in case of a medical emergency were recruited to participate in the study.
Patients were excluded from participation if they were (1) diagnosed with a significant hearing and/or visual impairment that prevented them from fully engaging in the music therapy intervention or completing written outcome measures; (2) unable to independently provide consent; (3) reporting active suicidal ideation during their hospital admission; (4) diagnosed with a severe psychological comorbidity (e.g., psychosis/schizophrenia) preventing them from fully engaging in the intervention; (5) admitted to an intensive care unit (ICU) at the time of screening; (6) receiving active cancer treatment; (7) diagnosed with a medical condition likely to be terminal within 24 weeks; (8) on a wait list for heart transplantation or ventricular assist device; (9) diagnosed with New York Heart Association (NYHA) Stage IV HF or end-stage COPD based on EHR documentation; (10) receiving hospice care; or (11) engaged in active substance abuse.
Eligibility criteria were modified during the trial to reduce barriers to enrollment. These modifications included (1) removing an initial inclusion criteria of reporting at least moderate depression (Patient Health Questionnaire [PHQ]− 9 [39] score ≥ 10) or anxiety (Generalized Anxiety Disorder [GAD]− 7 [40] score ≥ 10) as this required a long and burdensome screening process that hindered recruitment; (2) increasing the eligible age range from 40–89 to 30–89; and (3) excluding patients with confirmed or suspected COVID- 19, MRSA, or C.diff infection(s) as hospital policy prevented music therapists from working with these patients within their hospital rooms. Eligibility criteria changes did not alter the participant safety plan described below.
Ethics and consent
This study was conducted in accordance with the Declaration of Helsinki. This study was approved by the University Hospitals Cleveland Medical Center Institutional Review Board (STUDY20230897). Written, informed consent was obtained from all participants. The study is registered in clinicaltrials.gov (NCT06214325). Procedures utilized to protect participant safety included (1) storing patient identifiers in Research Electronic Data Capture (REDCap), a secure, web-based application designed to support structured data capture, log changes to data, and automate survey distribution for research studies [41]; (2) identifying participants by the number assigned to them at the beginning of the study rather than by name within the REDCap database and interview transcripts; (3) eliminating participants’ statements of their own names from transcripts; and (4) storing de-identified audio recordings of the participants’ interviews and music therapy interventions on a HIPAA-compliant cloud server.
Procedures
Screening and enrollment
Potentially eligible participants were initially identified through EHR or verbal referrals from medical teams or screening lists of patients admitted to the medical units where patients with COPD or HF were typically admitted. Flyers and other study advertisements were not used in this study. Patients meeting initial criteria based on age, diagnosis, primary language, and precautions were added to a list in the EHR. Study staff then approached these patients’ nurses and medical teams to obtain verbal referrals, determine whether patients were appropriate to approach for study participation, and confirm anticipated discharge dates. Patients referred at this stage were entered into the study’s REDCap database. The study coordinator then reviewed these patients’ health records to confirm whether they met additional eligibility criteria that could be evaluated using EHR data (e.g., terminal illness, substance abuse, psychological comorbidities). Following EHR review for initial eligibility, study staff then approached patients within their hospital rooms. After explaining study procedures, technology access was assessed by asking patients whether they had (1) an active email address, (2) access to and some degree of comfort with videoconferencing technology, (3) Wi-Fi at home, and (4) a mobile device with an active data plan. After confirming these technology-based criteria and patients’ access to a reliable support person, the study staff obtained written informed consent.
Baseline assessment
Immediately following informed consent, participants verified their contact information, completed a demographics survey, and completed measures including the Perceived Stress Scale- 4 (PSS- 4) and Patient Reported Outcome Measurement Information System (PROMIS) measures of self-efficacy, emotional support, instrumental support, and HRQoL via a REDCap survey delivered on an iPad.
Intervention
Planed study procedures included four music therapy sessions conducted by a board-certified music therapist (MT-BC). The first two sessions were performed in participants’ hospital rooms at least 24 hours apart. Following discharge, the study coordinator contacted participants to schedule their third and fourth music therapy sessions, which were provided virtually over Zoom. These virtual sessions were typically scheduled 7 days apart. Virtual sessions could be rescheduled based on participant availability up to 30 days post-discharge, thus the distance between sessions 3 and 4 varied from a minimum of 4 days to a maximum of 12 days (median and interquartile range [IQR] 6.5 [5.25, 7] days). To help participants navigate the videoconferencing platform, a printed “Zoom 101” document was provided to all participants at the time of enrollment. This document provided screenshot guides of procedures for downloading Zoom, joining virtual meetings, turning the camera on and off, muting/unmuting, and troubleshooting common videoconferencing challenges. Prior to their third session, the study coordinator hosted virtual technical assistance sessions with participants to help them practice skills such as logging into Zoom, turning their camera on, and unmuting themselves. In addition, the study coordinator mitigated common technical challenges by calling participants before their virtual sessions to help them join the Zoom call or connect to audio if needed.
Follow-up assessments
Participants were asked to complete PSS- 4 and PROMIS measures again at 15- and 30-days post-discharge. These intervals were chosen to understand participants’ self-efficacy, emotional support, instrumental support, and HRQoL after the completion of the fourth session (anticipated to be completed within two weeks following discharge) and at the cutoff for evaluating the 30-day readmission outcome. REDCap links to surveys were sent via text message using Twilio [42] with up to two subsequent reminders as needed.
Qualitative interview
Participants who reported being willing to be approached for an interview at the time of informed consent were randomized to determine whether they would be interviewed. Participants selected for interview were invited to complete a 30-minute semi-structured interview focused on their experience with the trial. This interview was conducted within 1 week following 30-days post-discharge.
Participant safety plan
Since the clinical trial asked sensitive questions pertaining to participants’ mental health, a system was developed to alert study staff and participants’ care teams if their responses to the four depression items on the PROMIS- 29 indicated elevated depression. Participants reporting responses of “often” or “always” on any of the four PROMIS Depression items were further assessed using the 9th item from the PHQ- 9 [39] which assesses thoughts of suicide or self-harm. If a participant reported a score ≥ 1 on this item, study staff were immediately notified via an automated REDCap alert. Study staff then notified that participant’s clinical care team (if they were still admitted) or collaborated with a pair of psychiatrists to contact the participant, assess for suicidal intent, and connect the participant to appropriate mental health resources as needed (if they were discharged). To help ensure timely response in such a scenario during business hours, 15- and 30-day follow up questionnaires were only sent on Mondays, Tuesdays, or Wednesdays.
Music therapy intervention
Development
The series of four music therapy interventions developed for this study were informed by (1) evidenced-based music therapy practices utilized in the medical setting [43]; (2) the principal investigator’s (PI) clinical and research experience providing music therapy among patients with other chronic illnesses [32]; and (3) feedback from music therapists who had several years of clinical experience providing music therapy interventions to patients with HF or COPD. The intervention was designed to provide education and practical music therapy exercises for adults with HF or COPD to easily access and practice every day via their own mobile devices to manage symptoms and improve HRQoL. The second author, a board-certified music therapist (MT-BC) with over 10 years of experience working with adults with chronic illness, provided all the music therapy interventions using the same standardized session plans.
Similar to prior music therapy clinical trials which tailored aspects of intervention delivery (e.g., music genre) to meet patients’ needs and preferences [44], additional strategies were deployed to help maintain fidelity. These included (1) providing standardized training covering the study protocol and clinical needs of patients with HF and COPD; (2) conducting role-playing exercises until adequate therapeutic, musical, and technological skills were displayed; (3) monitoring session dose, length, and intervention procedures using REDCap and session recordings to ensure consistent treatment delivery; (4) holding bi-weekly conference calls to discuss challenges, communicate updates, and answer therapists’ questions; and (5) ensuring appropriate receipt of treatment by training MT-BCs to use active questioning and behavioral observation to assess whether participants comprehended how to access music exercises.
Overview
Each participant was given the opportunity to engage in four music therapy sessions: two conducted while admitted to the hospital and two conducted virtually within 30 days following discharge. All sessions involved (1) setting an agenda, (2) an explanation of the music exercise, (3) a demonstration and live recording of the music exercise in which the MT-BC engaged the participant in practicing the music exercise (e.g., breathing, imagery, harmonica exercise), (4) time to process the participant’s response to the exercise, (5) time for the MT-BC to electronically deliver the music exercise to the participant and ensure they had all materials necessary to use the exercise at home, and (6) an assignment for the participant to practice the music exercise taught in that session at least once per day until the following music therapy session. Within each session, the MT-BC collaborated with participants to prioritize time for self-care and address barriers to engaging in the music therapy exercises.
The first two sessions were conducted in-person within participants’ hospital rooms at bedside. Session 1 (median [IQR] length 58 [52.25, 63] minutes) objectives included (1) introducing music therapy, (2) understanding the participant’s music preferences, (3) improvising music to reflect the participant’s experience with their symptoms and stressors, (4) providing education on the use of music to address symptoms of HF or COPD, and (5) providing a personalized live music listening intervention. Session 2 (41 [38.75, 48] minutes) began with a review of the content from session 1 followed by education and engagement in breathing exercises with either soothing rhythmic music co-created with the participant (for participants with HF) or with the use of the harmonica (for participants with COPD).
Sessions 3 and 4 were conducted within 30 days of discharge, with participants engaging in the session virtually on their own devices using Zoom. Given that (1) discharge disposition (e.g., to home, a family member’s residence, or a skilled nursing facility) was often unknown at the time participants were recruited and (2) controlling the location where participants could attend virtual sessions would have limited accessibility and generalizability, participants could attend virtual sessions from any post-discharge location (e.g., home or skilled nursing facility) so long as they were not readmitted to a hospital. Session 3 (55 [48, 57] minutes) reviewed content from session 2 and provided a personalized music-assisted relaxation and imagery intervention. Session 4 (60 [54.5, 65.5] minutes) served as a conclusion of the intervention, beginning with a discussion of what was learned in previous sessions, followed by the completion of a structured coping plan to help manage future stressors, and concluding with a gratitude songwriting intervention. A detailed description of each music therapy intervention in table and narrative format is provided in the Supplemental Material.
Music technology
All music therapy interventions were designed to be co-created with participants and simultaneously recorded in GarageBand, a free digital audio workstation developed for MacOS, so that the participant left with a practical music therapy exercise following each session. GarageBand allowed therapists to quickly create multiple tracks, record, mix, add loops and effects, and export audio files for participants. In-person sessions were conducted and recorded within a mobile music therapy studio. This plug-and-play studio on wheels included all the materials needed to facilitate and record sessions in the participant’s hospital room, was small enough to fit within smaller hospital rooms, and could be setup within a few minutes. The studio included a dynamic microphone, 2 sets of headphones for the MT-BC and participant to listen to the intervention privately without disturbing other patients and staff, a MacBook Air configured with GarageBand, a Zoom H6 multitrack audio interface, XLR and instrument cables, a guitar holder, an iPad, and a foldable stool. All GarageBand settings, effects, and levels were preset by the MT-BC prior to the session.
The MT-BC facilitated virtual sessions 3 and 4 within an office-based music therapy studio. To ensure that the sound created within GarageBand was transmitted accurately and with high fidelity, the Blackhole audio interface [45] was used to transmit audio from GarageBand through Zoom. The Zoom audio settings were also configured for “Original sound for musicians,” “High-fidelity music mode,” “Echo cancellation,” and “Stereo audio.” This afforded the opportunity for the participant to experience the high-quality audio simultaneously as the therapist composed and played it within the Zoom application on their own device. This environment also enabled the therapist to further personalize music therapy interventions through adding additional instruments (e.g., guitars, keyboards, drums, and strings), nature sounds, reverb, and other audio effects.
Renumeration
Out of respect for the time and effort participants gave to complete study procedures [46], participants received $20 at the conclusion of each virtual music therapy session (sessions 3 and 4) and $20 for every survey completed (15-and 30-days post discharge). They also received $20 for completing the interview. This is consistent with other clinical trials [32, 47]. Participants were issued ClinCard [48] prepaid debit cards during the enrollment session, and funds were loaded after completing each research activity described above.
Measures and data collection
Demographics and clinical characteristics
The following information was extracted from each participant’s medical record: age, primary diagnosis, insurance type, whether they were currently receiving home oxygen, presence of physical (e.g., diabetes, hypertension) and psychological (e.g., depression, anxiety) comorbidity diagnoses, healthcare utilization (i.e., hospital admissions and emergency department visits) within the past 12 months, and details related to adverse events. Insurance status has a significant effect on access to care among patients with HF [49] and COPD [50] in the US and was collected to better understand participants’ SES and ability to access health services. Adverse events including hospital readmissions, medical events (e.g., cerebrovascular accident, transfer to ICU), and psychiatric events (e.g., delirium) that would prevent study completion were also tracked. These events were evaluated by physicians on the study team to determine whether they warranted withdrawing participants from the study.
Participants self-reported the following information via a REDCap survey immediately following informed consent: gender, race, ethnicity, marital status, employment status, annual household income, whether they lived alone, smoking status (i.e., never, former, current), number of years living with their primary diagnosis, current engagement in psychological therapies, and prior self-reported involvement in music therapy. This demographics and clinical history survey was developed for this study by the research team.
Patient-reported outcome measures
Perceived stress was measured using the PSS- 4, a well-validated instrument for assessing stress perception in the general population [51] and designed to measure the degree to which situations in one’s life are appraised as stressful [52]. Previous studies have used the PSS to assess the relationship between perceived stress [53] and incident HF as well as acute care use among patients with COPD [27].
General self-efficacy, emotional support, instrumental support, and HRQoL were assessed using PROMIS measures [54], which are well-validated in multiple populations and scored on a general population-based T-score metric with a mean of 50 and an SD of 10 [54]. General self-efficacy, emotional support, and instrumental support were measured using 4-item short form versions of the measures. The PROMIS- 29 (a series of 4-item subscales of anxiety, depression, fatigue, sleep disturbance, and pain interference, where higher scores indicate greater severity of the specific symptom) was used to assess HRQoL. The PROMIS- 29 also includes 4-item subscales measuring ability to participate in social roles and activities and physical function. Higher scores indicate a greater ability to participate in social roles and activities and less severity for physical function impairment.
Feasibility
Rates of recruitment, retention, measure completion, session attendance, and music exercise use were collected to determine the feasibility of the MAJOR CHORD protocol and intervention. The PI and study coordinator also kept a log of study challenges and modifications which were reviewed in bi-weekly meetings.
Fidelity
Fidelity refers to the degree to which the delivery of an intervention adheres to the protocol or program developed [55]. Each music therapy session was recorded, and the MT-BC (second author) entered structured data documenting the music therapy session and adherence to steps of a manualized protocol. The PI reviewed all recordings and session documentation for the first 5 participants followed by every 5th participant thereafter and documented fidelity to the session plans within a structured form in REDCap. Fidelity rates were calculated as the total number of session plan tasks completed (e.g., introduction, education on diaphragmatic breath, processing the experience of the music exercise) divided by the total number of tasks.
Acceptability
Feasibility and acceptability were further assessed using a semi-structured interview. All interviews were conducted and recorded by the study coordinator. Interview guide prompts focused on (1) intervention acceptability (e.g., whether music fit participants’ preferences, challenges with participating in the intervention, relationship with the music therapist); (2) barriers to completing music therapy sessions within the hospital and at home (e.g., scheduling challenges, hospital staff interruptions, connectivity issues); (3) experience with completing the home music therapy exercises (e.g., consistency, barriers and facilitators of engagement); (4) the impact of the intervention on their physical and mental health; and (5) whether anything could have been done differently to improve the sessions.
Data analysis
Baseline characteristics
Descriptive statistics including median, IQR, counts, and percentages were conducted to summarize baseline characteristics. Median and IQR were chosen given the small sample size and lack of normally distributed data. Baseline PROMIS measures were converted to T-scores using HealthMeasures scoring service [56] and summarized using descriptive statistics and boxplots. Given the purpose of this study (i.e., feasibility and refinement), small sample size, limited response rates at 15- and 30-days, and guidance from the NCCIH [36] to not conduct inferential statistics of outcome effects within pilot studies, descriptive statistics of follow-up PROMs were not summarized or compared to baseline.
Feasibility
Counts and percentages were used to summarize rates of recruitment and retention. Measures of attendance, measure completion, and music exercise use were summarized among all recruited and all retained participants. Additionally, challenges presented and solutions implemented over the course of the trial were summarized in a table. A specific feasibility threshold was not set for this study as (1) the primary goal was to refine the intervention and data collection procedures prior to conducting a larger feasibility RCT in which feasibility thresholds will be specified; (2) similar pilot and feasibility studies of music therapy among patients with chronic illness did not set such thresholds [32,33,34,35]; and (3) there are no prior hybrid music therapy studies for direct comparison describing recruitment, session attendance, or measure completion rates within this population.
Fidelity
Rates of checklist adherence were compared to an established 80% threshold for examining fidelity of a music therapy intervention conducted among children with cancer and their parents [44].
Acceptability
For the qualitative data, all interviews were recorded, professionally transcribed, and checked for accuracy. The fourth and senior authors independently analyzed the interviews using conventional qualitative content analysis [57] in which information is extracted directly from participants’ comments without imposing preconceived categories or philosophical perspectives. In all cases, each assigned transcript was reviewed line-by-line and independently coded using a constant, comparative method of qualitative data analysis [57]. All data from the interviews that appeared to be directly related to the study aims were extracted. Any coding discrepancies were discussed between the coders until consensus was achieved. The coded data were then organized into categories to identify themes. Findings from the independent analyses were consolidated and presented to the study team. Members of the research team reviewed findings for accuracy of generated themes, interpretations of the data, and conclusions. Descriptive statistics, tables, and figures were generated using R Version 4.4.1 [58] and RStudio Version 2024.04.2 + 764 [59]. Qualitative analysis was conducted using NVivo v14.0, QSR international, Melbourne, Australia.
Results
Demographics and clinical characteristics
The demographics of the study population are described in Table 1. The median age of all participants was 61.5 years (range 44–77 years), with the majority identifying as female (65%) and non-Hispanic (100%). Eleven (55%) participants identified as White, and 35% identified as Black or African American. Most participants (60%) reported an annual household income of less than $50,000, 35% of the participants reported being unable to work, and 35% were Medicaid beneficiaries.
The clinical characteristics of the study population are presented in Table 2. Most participants were diagnosed with HF (80%). Among all participants, there was a high prevalence of anxiety (50%) and depressive disorders (35%). Other clinically relevant comorbidities among study participants included hypertension (85%), diabetes (45%), being a current or former smoker (75%), and hyperlipidemia (40%). Among participants with HF, most (62.5%) were classified as Class III according to the NYHA classification system demonstrating high disease burden.
Baseline PROMs
Baseline PROMs among all participants are summarized in Supplemental Table 1 and Supplemental Figure 1. Participants reported values (median [IQR]) on PROMIS measures that were more severe than those reported by the normal population (T-score = 50) [54] in several domains. These included higher than normal anxiety (58.70 [53.70, 63.50]), fatigue (63.70 [55.45, 66.75]), pain interference (66.10 ([55.70, 68.85]), and sleep disturbance (60.20 [52.10, 61.90]) as well as lower than normal physical function (32.55 [28.70, 37.90]), and ability to participate in social roles and activities (37.30 [36.45, 42.40]).
Feasibility
Table 3 summarizes measures of recruitment, retention, attendance, measure completion, and music exercise use, while Fig. 1 presents a CONSORT diagram of study participants. Of 113 patients approached, 75 (66.4%) were screened after expressing at least some interest in participating, 30 (26.5%) were deemed eligible, and 20 (17.7%) were enrolled. Of the 20 enrolled participants, 17 (85%) were retained, and three withdrew due to experiencing a medical or psychiatric adverse event unrelated to the music therapy intervention during their hospital admission. On average, across 15.29 weeks of recruitment, 14.1 patients were referred, 7.4 patients were approached, and 1.3 patients were enrolled per week.
Among all enrolled participants (N = 20), 46/80 (57.5%) music therapy sessions were attended, with 30/40 (75.0%) in-person and 16/40 (40.0%) virtual sessions attended. All but one participant (95%) attended ≥ 1 session, while only 3 (15%) attended all 4. All 46 sessions that were initiated were completed without being halted due to participants’ medical conditions, procedures, or technical challenges. Among retained participants (N = 17), 44/68 (64.7%) music therapy sessions were attended, with 28/34 (82.4%) of in-person and 16/34 (47.1%) of virtual session attended. Of these 17 participants, 9 (52.9%) completed 15-day measures, 12 (70.6%) completed 30-day follow-up measures, and 10 (58.8%) reported at least one instance of using one of the music therapy exercises taught over the course of the intervention.
Table 4 presents a list of challenges and corresponding solutions that were discovered and implemented over the course of the trial. Many of these challenges concerned communication with participants post-discharge and logistics related to recruitment and technical assistance. The solutions identified were based on analysis from the pilot and discussions among study team members.
Fidelity
The MT-BC demonstrated high fidelity (> 80%) across all sessions that were reviewed. Median [IQR] session fidelity rates (total number of session plan tasks completed divided by the total number of tasks) were as follows: Session 1 (95.1% [91.5, 97.6]), Session 2 among patients with COPD (92.0% [90.0, 94.0]), Session 2 among patients with HF (95.0% [92.5, 97.5]), Session 3 (94.4% [91.7, 95.8]), and Session 4 (96.2% [88.5, 96.2]).
Acceptability
Three major themes emerged from the analysis of five semi-structured interviews (1) the therapeutic relationship facilitated a positive intervention experience, (2) need for strategies to improve post-discharge engagement in the intervention, and (3) impact on mental health. Quotes illustrating these three themes are presented along with their descriptions below.
The therapeutic relationship facilitated a positive intervention experience
All interview participants generally agreed that the length, convenience, and timing of the music therapy intervention were acceptable. A few participants remarked on the benefits of the intervention for breaking up the monotony of the hospitalization, with one participant stating:
“In the hospital setting, you actually look forward to anything that is a change in routine, because there’s not much to look forward to. There were so many restrictions on my diet that the meals were nothing to even look forward to. That (music therapy) was really the bright point of my day.”
Several participants discussed the importance of the MT-BC in facilitating their engagement with the intervention, providing helpful instructions, and tailoring the intervention to their preferences.
“Oh, she never seemed rushed, and she’s a very nice person. I’m not good at playing the harmonica, so it’s a little embarrassing for me to blow on the harmonica with her sitting there, but it’s her job and she made me more comfortable, she was very good.”
“That was the other part of it. It actually works. That was I guess the ice cream on top of the cake. When you first hear it, you’re like, ‘Yeah. Right,’ but if you listen and follow her directives, the breathing techniques and all that, she calmed you right out.”
“In that last one, we did a remake of Otis Redding’s Sitting on the Dock of the Bay. Man, she had birds and creek water running in the music. It was really nice. That just happened to be one of my favorite songs. I’m sitting there, got to breathing, and the next thing you know, I was on the dock of the bay. She was able to transport you there.”
Need for strategies to improve post-discharge engagement in the intervention
Though participants discussed using music exercises such as harmonica playing after they were discharged, they also shared barriers to attending virtual sessions and engaging in the music exercises. These barriers were often related to forgetting to practice, social stressors (e.g., a family member in the hospital), or medical appointments such as dialysis. A few participants expressed a preference for the in-person sessions, not only for the personal connection but also because they presented fewer technological challenges. As one participant stated, “holding the tablet and doing the Zoom is sort irritating for me.”
Though technical assistance sessions were offered virtually after discharge, several participants expressed a desire for in-person technical assistance prior to discharge. When asked about whether such a visit prior to discharge would have been helpful, one participant stated:
“It probably would’ve, ‘cause I’ve never done it before. I didn’t even know what Zoom was, until they explained it to me. I understand. I get the concept. If you had a meeting with somebody and they lived in England and the other person in your company lived in Mexico...I get it, and it makes sense, but I never had to do that.”
Impact on mental health
Participants described how the music therapy intervention not only provided an immediate effect in reducing their stress and promoting relaxation, but also gave them new skills for managing stress and anxiety in their lives outside of the scheduled music therapy sessions.
“Well it created less stress. Less things to focus on, and I was gonna focus on the music and not the things that were stressing me out.”
“I’ve always had trouble shutting down my mind. Sometimes I would come home angry from work and would be in bed five hours and I would honestly be able to say I never slept a wink. I’ve always been that way, but this helped a little bit.”
Several participants used the term “escape” to describe their experience with how the music therapy intervention helped to refocus their attention away from negative emotions and experiences.
“When I do them, it’s like you connect with the music, and that kind of takes your mind off of the negative stuff you’re dealing with. It’s like a mental escape, because it does take mental concentration to follow the rhythms, and you’re listening to the music. When you’re listening to the music, your mind’s not going 100 places at once. My wife’s in Assisted Living. She’s doing well in some ways, and some ways she’s having problems…It’s a safe haven from all of that.”
“Of course when I was playing along with her, that was a jam session. It takes you right out of the hospital room and puts you right in the club. So I was able to escape for a minute…So if you can get to that level of escapism, of putting yourself there, that kind of Zen moment, it does a lot. It does a lot for your day. It clears your head. You’ve just got to get there.”
Discussion
The purpose of this single-arm study was to examine the feasibility, fidelity, and acceptability of the MAJOR CHORD intervention and collection of PROMs through 30 days after hospital discharge. A major focus of this study was to determine which modifications (if any) would need to be made to the intervention and data collection procedures prior to initiating a feasibility RCT. As the first study to investigate the feasibility and acceptability of performing in-person and virtual music therapy sessions among patients with COPD or HF during and after their hospitalizations, the results of this study help lay the foundation for future research on the impact of longitudinal music therapy exposure on HRQoL and hospital readmission rates.
Baseline characteristics of the participants were similar to the demographic profile of patients seen at University Hospitals Cleveland Medical Center [60] and clinical characteristics reported in other studies among people with HF or COPD. The socio-demographic profile of the present study population was similar to that of Cleveland, Ohio where many individuals from low-income racial minority populations reside. For comparison, the average reported income for Cleveland residents in 2022 was $37,351 while 60% of participants in this study reported earning < $50,000 per year. Similarly, 65% of Cleveland residents identified as either non-white or multiracial which is similar to the present study population (45% non-white) [61]. Furthermore, comorbidities prevalent within this sample such as hypertension, anxiety, and depressive disorders are consistent with prior descriptions of HF and COPD populations [62,63,64]. Given the negative impact of social determinants of health on mental and physical health outcomes and the effects these determinants and comorbidities have on hospital readmission risk [65], these results support the feasibility of recruiting a study population at high risk for hospital readmission. Future music therapy research with this population should consider the impact of these social determinants on PROMs and utilization outcomes.
In examining baseline PROMs, participants in this study reported HRQoL scores that were more severe when compared to the general population. This is consistent with prior studies among patients with HF [66] and COPD [67] and studies demonstrating the positive relationship between HRQoL impairment and readmission risk [2, 8]. Given these baseline results, it appears this study was successful in recruiting a population for which HRQoL was a challenge and HRQoL improvements may potentially be observed over the course of a multi-session music therapy intervention.
For this pilot study, 17.7% of approached patients were recruited. Primary reasons for non-enrollment included lack of interest (38 before in-person screening and 6 after being deemed eligible) and multiple exclusion criteria uncovered following in-person screening (45/113). Among the 45 patients not recruited due to exclusion criteria uncovered at the time of screening, the most common reasons included (1) not having access to technology needed for virtual participation (51.1%); (2) having an anticipated discharge date < 2 days from the time of screening, which prevented the delivery of the two in-person music therapy sessions (15.6%); and (3) not screening positive for at least moderate depression or anxiety (15.5%). To address the technology barrier, future trials investigating virtual music therapy intervention models should consider providing resources such as tablets with pre-configured data plans or a connection to community resources that provide free or discounted broadband access. Confirming discharge dates was a challenge throughout the study as these shifted each day based on providers’ evaluations and were not always updated in the EHR. To help verify discharge dates in the future feasibility RCT, research assistants will confirm dates with the nurses rather than relying solely on what is documented in the EHR.
The moderate depression and/or anxiety inclusion criteria were removed for three reasons. First, administering the PHQ- 9 and GAD- 7 screenings required the study team to administer an entire screening consent form that made the recruitment process lengthier and more burdensome for patients. Second, as observed in the median PROMIS depression (56.70) and anxiety (58.70) scores, a population reporting elevated depression and anxiety symptoms was still enrolled even without the PHQ- 9 and GAD- 7. Third, the target population for a future definitive study would still be at high risk for readmission (future primary outcome) given their diagnosis and comorbidities even without meeting the moderate depression and/or anxiety threshold. Finally, by removing these more stringent mental health criteria, future studies may be more generalizable to adult patients admitted with HF or COPD who may not meet moderate depression and/or anxiety criteria.
Compared to prior psychosocial intervention studies among patients with HF, the observed recruitment rate was lower than a trial investigating a group psychosocial intervention (Adult Congenital Heart Disease-Coping and Resilience program) among adults with congenital heart disease (36.3%) and higher than a study investigating meditation (0.59%) [68, 69]. Compared to the trial among adults with congenital heart disease which only delivered interventions within the hospital, the lower recruitment rate in the present study may be explained by the trial adding additional virtual services to patients’ original treatment plans following discharge [68]. Unlike the study of meditation which screened all patients within a large academic hospital, this study only began screening patients following a referral from their medical team, which may help explain the relatively higher recruitment rate [69].
When comparing rates to other music therapy studies, the observed recruitment rate was lower than recent multi-session music therapy studies among adults with chronic pain such as Bradt et al. (77%) [33], Low et al. (56%) [34], and Rodgers-Melnick et al. (89%) [32]. However, these studies recruited from outpatient settings in which participants had a history of attending treatments rather than an inpatient setting as in this study. Furthermore, these studies did not involve virtual delivery and did not include participants with the same degree of comorbidity burden. Recruitment rates were similar to a recent feasibility trial of a virtual music imagery intervention among veterans with chronic pain (12.9% of patients sent recruitment letters) [35]. This single-arm study among veterans was similar to ours as it involved preliminary screening before approaching patients, virtual music therapy sessions, and targeting patients suffering from chronic illness. Given the demonstrated retention rate (85%), attendance rate among retained participants (64.7%), and 100% music therapy session completion rate among initiated sessions, these results provide early support for the feasibility of the MAJOR CHORD protocol among adults with COPD and HF, but modifications are needed to improve overall session attendance (17.6% among retained) and measure completion.
There were numerous challenges to implementation that warrant modification in the future feasibility RCT and any subsequent RCTs examining efficacy (Table 4). In addition to difficulties with recruitment which were addressed with modifying the inclusion and exclusion criteria, several challenges were encountered with participant retention following discharge. On multiple occasions, the study coordinator was unable to reach participants via phone after discharge to schedule the virtual music therapy sessions. There were also challenges with participants not showing up to scheduled virtual sessions, which required the study team to make frequent rescheduling calls. The gap in communication post-discharge might have been due to the high prevalence of mild cognitive impairment observed among patients with COPD and HF [70, 71]. To improve communication efficiency and accessibility for the RCT while considering the cognitive barriers faced by this study population, the future feasibility RCT will use MyCap, an app within REDCap that participants and the study team can utilize to send secure text messages to each other. In addition, one person will be designated for communicating with participants post-discharge to prevent confusion which can occur when participants receive communications from different study team members over the course of the study. Future studies could also consider measuring satisfaction with the virtual sessions using quantitative measures to further understand acceptability and inform intervention refinements.
Results from the qualitative analysis support the acceptability of the intervention and its potential to address mental health outcomes among patients with COPD or HF. Results are consistent with prior music therapy literature in which (1) participants with chronic pain began integrating music exercises within their lives to manage their stress and symptoms [32,33,34], (2) the music intervention provided a means of refocusing attention away from negative emotions [72], and (3) the MT-BCs were an essential component of the intervention for addressing patients’ needs [72, 73]. These preliminary qualitative results also support use of the current set of PROMs to measure the impact of this intervention on stress, mood, and self-efficacy – a critically important domain which has been shown to mediate the effects of music therapy among patients with advanced cancer [74]. Given the low virtual session attendance observed and participants’ expressed desire for in-person technology assistance, the future RCT will include time for the research assistant to practice Zoom procedures with participants prior to discharge.
Limitations of this study included a small sample size within a single site, lack of a comparison group to inform recruitment and retention rates within an RCT, and a relatively short follow up period. The sample of patients with COPD (n = 4) was particularly small. Thus, current findings may not inform feasibility of this study protocol for this population. Due to the randomized interview assignment, several participants were not interviewed, including participants who demonstrated poor attendance and measure completion and may have informed barriers to completing the study protocol within a semi-structured interview. Despite these limitations, this study featured several strengths and novel innovations including (1) implementing standardized and manualized music therapy interventions tailored to participants’ preferences; (2) the novel use of music technology to deliver high-quality virtual sessions; (3) the nuanced understanding of study outcomes provided through integrating quantitative and qualitative data; and (4) the use text-based surveys, which removed the need for participants to return to the healthcare facility.
Conclusion
Overall, preliminary findings support the feasibility and acceptability of a 4-session hybrid music therapy intervention among adults with COPD or HF during and after their hospital admissions. However, modifications are needed to improve recruitment rate, session attendance, and measure completion after discharge. The valuable data collected from this pilot study will be used to improve study procedures in a future feasibility RCT. Lessons learned from this study may be applicable to other psychosocial interventions delivered in this context.
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118(17):3272–87. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/cvr/cvac013.
Ryan CJ, Bierle RS, Vuckovic KM. The three Rs for preventing heart failure readmission: review, reassess, and reeducate. Crit Care Nurse. 2019;39(2):85–93. https://doiorg.publicaciones.saludcastillayleon.es/10.4037/ccn2019345.
Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–58. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/S2213-2600(21)00511-7.
Press VG, Konetzka RT, White SR. Insights about the economic impact of chronic obstructive pulmonary disease readmissions post implementation of the hospital readmission reduction program. Curr Opin Pulm Med. 2018;24(2):138–46. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/mcp.0000000000000454.
Lesyuk W, Kriza C, Kolominsky-Rabas P. Cost-of-illness studies in heart failure: a systematic review 2004–2016. BMC Cardiovasc Disord. 2018;18(1):74. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12872-018-0815-3.
Cook C, Cole G, Asaria P, Jabbour R, Francis DP. The annual global economic burden of heart failure. Int J Cardiol. 2014;171(3):368–76. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ijcard.2013.12.028.
Goldgrab D, Balakumaran K, Kim MJ, Tabtabai SR. Updates in heart failure 30-day readmission prevention. Heart Fail Rev. 2019;24(2):177–87. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s10741-018-9754-4.
Kong CW, Wilkinson TMA. Predicting and preventing hospital readmission for exacerbations of COPD. ERJ Open Res. 2020;6(2). https://doiorg.publicaciones.saludcastillayleon.es/10.1183/23120541.00325-2019.
Hospital readmissions reduction program (HRRP). 2023. https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps/hospital-readmissions-reduction-program-hrrp. Accessed 3 July 2024.
Benjenk I, Chen J. Effective mental health interventions to reduce hospital readmission rates: a systematic review. J Hosp Manag Health Policy. 2018;2. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/jhmhp.2018.08.05.
Dekker RL, Moser DK, Peden AR, Lennie TA. Cognitive therapy improves three-month outcomes in hospitalized patients with heart failure. J Card Fail. 2012;18(1):10–20. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.cardfail.2011.09.008.
Sohanpal R, Pinnock H, Steed L, Heslop Marshall K, Chan C, Kelly M, et al. Tailored, psychological intervention for anxiety or depression in people with chronic obstructive pulmonary disease (COPD), TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD): protocol for a randomised controlled trial. Trials. 2020;21(1):18. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13063-019-3800-y.
Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333(18):1190–5. https://doiorg.publicaciones.saludcastillayleon.es/10.1056/NEJM199511023331806.
Zhang Y, Lv X, Jiang W, Zhu Y, Xu W, Hu Y, et al. Effectiveness of a telephone-delivered psycho-behavioural intervention on depression in elderly with chronic heart failure: rationale and design of a randomized controlled trial. BMC Psychiatry. 2019;19(1):161. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12888-019-2135-2.
Bhatt SP, Patel SB, Anderson EM, Baugh D, Givens T, Schumann C, et al. Video telehealth pulmonary rehabilitation intervention in chronic obstructive pulmonary disease reduces 30-day readmissions. Am J Respir Crit Care Med. 2019;200(4):511–3. https://doiorg.publicaciones.saludcastillayleon.es/10.1164/rccm.201902-0314LE.
Gorodeski EZ, Moennich LA, Riaz H, Jehi L, Young JB, Tang WHW. Virtual versus in-person visits and appointment no-show rates in heart failure care transitions. Circ Heart Fail. 2020;13(8):e007119. https://doiorg.publicaciones.saludcastillayleon.es/10.1161/CIRCHEARTFAILURE.120.007119.
American Music Therapy Association: What is Music Therapy? | What is Music Therapy? | American Music Therapy Association (AMTA). 2021. https://www.musictherapy.org/about/musictherapy/. Accessed 24 March 2021.
de Witte M, Pinho ADS, Stams GJ, Moonen X, Bos AER, van Hooren S. Music therapy for stress reduction: a systematic review and meta-analysis. Health Psychol Rev. 2022;16(1):134–59. https://doiorg.publicaciones.saludcastillayleon.es/10.1080/17437199.2020.1846580.
Lee JH. The effects of music on pain: a meta-analysis. J Music Ther. 2016;53(4):430–77. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/jmt/thw012.
Lu G, Jia R, Liang D, Yu J, Wu Z, Chen C. Effects of music therapy on anxiety: a meta-analysis of randomized controlled trials. Psychiatry Res. 2021;304:114137. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.psychres.2021.114137.
Zhao K, Bai ZG, Bo A, Chi I. A systematic review and meta-analysis of music therapy for the older adults with depression. Int J Geriatr Psychiatry. 2016;31(11):1188–98. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/gps.4494.
Alexander JL, Wagner CL. Is harmonica playing an effective adjunct therapy to pulmonary rehabilitation? Rehabil Nurs J. 2012;37(4):207–12. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/rnj.33.
Bryant MS, Bandi VD, Nguyen CK, Lan C, Henson HK, Sharafkhaneh A. Telehealth pulmonary rehabilitation for patients with severe chronic obstructive pulmonary disease. Fed Pract. 2019;36(9):430–5.
Okada K, Kurita A, Takase B, Otsuka T, Kodani E, Kusama Y, et al. Effects of music therapy on autonomic nervous system activity, incidence of heart failure events, and plasma cytokine and catecholamine levels in elderly patients with cerebrovascular disease and dementia. Int Heart J. 2009;50(1):95–110. https://doiorg.publicaciones.saludcastillayleon.es/10.1536/ihj.50.95.
Khan SH, Kitsis M, Golovyan D, Wang S, Chlan LL, Boustani M, et al. Effects of music intervention on inflammatory markers in critically ill and post-operative patients: a systematic review of the literature. Heart Lung. 2018;47(5):489–96. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.hrtlng.2018.05.015.
Harris KM, Jacoby DL, Lampert R, Soucier RJ, Burg MM. Psychological stress in heart failure: a potentially actionable disease modifier. Heart Fail Rev. 2021;26(3):561–75. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s10741-020-10056-8.
Parekh TM, Cherrington AL, Bhatia S, Turan B, Patel SB, Kim YI, et al. the association of low income and high stress with acute care Use in COPD patients. Chronic Obstr Pulm Dis. 2020;7(2):107–17. https://doiorg.publicaciones.saludcastillayleon.es/10.15326/jcopdf.7.2.2019.0165.
Rodgers-Melnick SN, Rivard RL, Block S, Dusek JA. Effectiveness of medical music therapy practice: integrative research using the electronic health record: rationale, design, and population characteristics. J Integr Complement Med. 2023;0(0):null. https://doiorg.publicaciones.saludcastillayleon.es/10.1089/jicm.2022.0701.
Mondanaro JF. Challenges to music therapy programming: a case study of innovation, burden, and resilience in United States hospitals. Music Med. 2019;11(2):115–26. https://doiorg.publicaciones.saludcastillayleon.es/10.47513/mmd.v11i2.666.
Lale A, Ntourntoufis P. Individual music psychotherapy and psychosis: understanding and measuring relative effectiveness through rates of readmission. Br J Music Ther. 2020;34(1):19–29. https://doiorg.publicaciones.saludcastillayleon.es/10.1177/1359457520911011.
Loewy J, Goldsmith C, Deshpande S, Sun A, Harris J, van Es C, et al. Music therapy in pediatric asthma improves pulmonary function while reducing hospitalizations. J Asthma. 2021;58(5):674–82. https://doiorg.publicaciones.saludcastillayleon.es/10.1080/02770903.2020.1712725.
Rodgers-Melnick SN, Lin L, Gam K, Souza de Santana Carvalho E, Jenerette C, Rowland DY, et al. Effects of music therapy on quality of life in adults with sickle cell disease (MUSIQOLS): a mixed methods feasibility study. J Pain Res. 2022;15:71–91. https://doiorg.publicaciones.saludcastillayleon.es/10.2147/JPR.S337390.
Bradt J, Norris M, Shim M, Gracely EJ, Gerrity P. Vocal music therapy for chronic pain management in inner-city African Americans: a mixed methods feasibility study. J Music Ther. 2016;53(2):178–208. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/jmt/thw004.
Low MY, Lacson C, Zhang F, Kesslick A, Bradt J. Vocal music therapy for chronic pain: a mixed methods feasibility study. J Altern Complement Med. 2020;26(2):113–22. https://doiorg.publicaciones.saludcastillayleon.es/10.1089/acm.2019.0249.
Story KM, Robb SL, Bravata DM, Damush TM, Bair MJ. Telehealth engaged music for pain outcomes: a music and imagery proof-of-concept study with veterans. J Music Ther. 2024. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/jmt/thae011.
National Center for Complementary and Integrative Health: Pilot Studies: Common Uses and Misuses | NCCIH. 2021. https://www.nccih.nih.gov/grants/pilot-studies-common-uses-and-misuses. Accessed 5 Apr 2021.
Creswell JW. A concise introduction to mixed methods research. Thousand Oaks: SAGE Publications Ltd; 2015.
Burns DS, Robb SL, Haase JE. Exploring the feasibility of a therapeutic music video intervention in adolescents and young adults during stem-cell transplantation. Cancer Nurs. 2009;32(5):E8–16. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/NCC.0b013e3181a4802c.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13. https://doiorg.publicaciones.saludcastillayleon.es/10.1046/j.1525-1497.2001.016009606.x.
Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7. https://doiorg.publicaciones.saludcastillayleon.es/10.1001/ARCHINTE.166.10.1092.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jbi.2008.08.010.
Twilio. https://www.twilio.com/en-us. Accessed 8 Sept 2024.
Rodgers-Melnick SN, Rivard RL, Block S, Dusek JA. Effectiveness of music therapy within community hospitals: an EMMPIRE retrospective study. PAIN Reports. 2023;8(3):e1074. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/pr9.0000000000001074.
MacLean JA, Stegenga KA, Henley AK, Robb SL. Implementing NIH behavior change consortium treatment fidelity recommendations in a multi-site randomized controlled trial of an active music engagement intervention for young children with cancer and parents. Integr Cancer Ther. 2022;21:15347354221140492. https://doiorg.publicaciones.saludcastillayleon.es/10.1177/15347354221140491.
Existential Audio: BlackHole Route Audio Between Apps. 2024. https://existential.audio/blackhole/. Accessed 6 Oct 2024.
Largent EA, Fernandez Lynch H. Paying research participants: regulatory uncertainty, conceptual confusion, and a path forward. Yale J Health Policy Law Ethics. 2017;17(1):61–141.
Dusek JA, Kallenberg GA, Hughes RM, Storrow AB, Coyne CJ, Vago DR, et al. Acupuncture in the emergency department for pain management: a BraveNet multi-center feasibility study. Medicine (Baltimore). 2022;101(9):e28961. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/md.0000000000028961.
Clincard. www.clincard.com. Accessed 15 Aug 2024.
Heidenreich PA, Fonarow GC, Opsha Y, Sandhu AT, Sweitzer NK, Warraich HJ, et al. Economic issues in heart failure in the United States. J Card Fail. 2022;28(3):453–66. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.cardfail.2021.12.017.
Siu DCH, Gafni-Lachter L. Addressing barriers to chronic obstructive pulmonary disease (COPD) care: three innovative evidence-based approaches: a review. Int J Chron Obstruct Pulmon Dis. 2024;19(null):331–41. https://doiorg.publicaciones.saludcastillayleon.es/10.2147/COPD.S426050.
Vallejo MA, Vallejo-Slocker L, Fernández-Abascal EG, Mañanes G. Determining factors for stress perception assessed with the perceived stress scale (PSS-4) in Spanish and other European samples. Front Psychol. 2018;9:37. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fpsyg.2018.00037.
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385–96. https://doiorg.publicaciones.saludcastillayleon.es/10.2307/2136404.
Balkan L, Ringel JB, Levitan EB, Khodneva YA, Pinheiro LC, Sterling MR, et al. Association of perceived stress with incident heart failure. J Card Fail. 2022;28(9):1401–10. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.cardfail.2022.04.013.
Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63(11):1179–94. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jclinepi.2010.04.011.
Gaden TS, Gold C, Assmus J, Kvestad I, Stordal AS, Bieleninik Ł, et al. Treatment fidelity in a pragmatic clinical trial of music therapy for premature infants and their parents: the LongSTEP study. Trials. 2023;24(1):160. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13063-022-06971-w.
HealthMeasures Scoring Service. https://www.assessmentcenter.net/ac_scoringservice. 2021. Accessed 11 July 2024.
Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88. https://doiorg.publicaciones.saludcastillayleon.es/10.1177/1049732305276687.
R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2022.
R Studio Team. RStudio: integrated development for R. Boston: RStudio, PBC; 2020.
HIP Cuyahoga. 2019 Community Health Assessment. 2019.
Bureau US: Cleveland City, Ohio. https://data.census.gov/profile/Cleveland_city,_Ohio?g=160XX00US3916000#race-and-ethnicity. Accessed 15 Aug 2024.
Celano CM, Villegas AC, Albanese AM, Gaggin HK, Huffman JC. Depression and anxiety in heart failure: a review. Harv Rev Psychiatry. 2018;26(4):175–84. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/hrp.0000000000000162.
Loosen SH, Roderburg C, Curth O, Gaensbacher J, Joerdens M, Luedde T, et al. The spectrum of comorbidities at the initial diagnosis of heart failure a case control study. Sci Rep. 2022;12(1):2670. https://doiorg.publicaciones.saludcastillayleon.es/10.1038/s41598-022-06618-5.
Santos NCD, Miravitlles M, Camelier AA, Almeida VDC, Maciel R, Camelier FWR. Prevalence and impact of comorbidities in individuals with chronic obstructive pulmonary disease: a systematic review. Tuberc Respir Dis (Seoul). 2022;85(3):205–20. https://doiorg.publicaciones.saludcastillayleon.es/10.4046/trd.2021.0179.
Alegría M, NeMoyer A, Falgàs Bagué I, Wang Y, Alvarez K. Social determinants of mental health: where we are and where we need to go. Curr Psychiatry Rep. 2018;20(11):95. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s11920-018-0969-9.
Roalfe AK, Taylor CJ, Hobbs FDR. Long term changes in health-related quality of life for people with heart failure: the ECHOES study. ESC Heart Fail. 2023;10(1):211–22. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/ehf2.14182.
Kharbanda S, Anand R. Health-related quality of life in patients with chronic obstructive pulmonary disease: a hospital-based study. Indian J Med Res. 2021;153(4):459–64. https://doiorg.publicaciones.saludcastillayleon.es/10.4103/ijmr.IJMR_1812_18.
Kovacs AH, Grace SL, Kentner AC, Nolan RP, Silversides CK, Irvine MJ. Feasibility and outcomes in a pilot randomized controlled trial of a psychosocial intervention for adults with congenital heart disease. Can J Cardiol. 2018;34(6):766–73. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.cjca.2018.02.023.
Heo S, McSweeney J, Ounpraseuth S, Shaw-Devine A, Fier A, Moser DK. Testing a holistic meditation intervention to address psychosocial distress in patients with heart failure: a pilot study. J Cardiovasc Nurs. 2018;33(2):126–34.
Yohannes AM, Chen W, Moga AM, Leroi I, Connolly MJ. Cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: a systematic review and meta-analysis of observational studies. J Am Med Dir Assoc. 2017;18(5):451.e1-.e11. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jamda.2017.01.014.
Goyal P, Didomenico RJ, Pressler SJ, Ibeh C, White-Williams C, Allen LA, et al. Cognitive impairment in heart failure: a heart failure society of America scientific statement. J Card Fail. 2024;30(3):488–504. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.cardfail.2024.01.003.
Rodgers-Melnick SN, Matthie N, Jenerette C, Griest Pell TJ, Lane D, Fu P, et al. The effects of a single electronic music improvisation session on the pain of adults with sickle cell disease: a mixed methods pilot study. J Music Ther. 2018;55(2):156–85. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/jmt/thy004.
Bradt J, Potvin N, Kesslick A, Shim M, Radl D, Schriver E, et al. The impact of music therapy versus music medicine on psychological outcomes and pain in cancer patients: a mixed methods study. Support Care Cancer. 2015;23(5):1261–71. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00520-014-2478-7.
Bradt J, Leader A, Worster B, Myers-Coffman K, Bryl K, Biondo J, et al. Music therapy for pain management for people with advanced cancer: a randomized controlled trial. Psychooncology. 2024;33(10):e70005. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/pon.70005.
Acknowledgements
We thank the individuals who participated in this study. We would also like to thank the team members who made this study possible including (1) research assistants Peter Roman, MD, Jaclyn Druso, DNP, CNP, Tyra Teauge, and Varun Natarajan, BS; (2) collaborating psychiatrists Philipp Dines, MD and Basem Alsarraj, MD; (3) Jaime (Abe) Pérez, PhD for developing the randomization module; and (4) contributors including Jeffery A. Dusek, PhD, Forrest Paquin, MT-BC, Samantha Huffman, MT-BC, and Tracey L. Baker (transcriptionist). We especially appreciate the support of Nancy McCann, Deforia Lane, PhD, MT-BC, and Anita Louise Steele, MM, MT-BC.
Funding
This work was supported by the Kulas Foundation in Cleveland, OH [Grant no. K23030M]. UH REDCap (Version 14.6.9) is supported by the Clinical and Translational Science Collaborative of Northern Ohio, which is funded by the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Science Award grant, UM1TR004528.
Author information
Authors and Affiliations
Contributions
HY served as a research assistant, administered the REDCap surveys, and led the draft of the initial manuscript. AF provided the music therapy interventions for this study and drafted the intervention description in the supplemental material. TS served as study coordinator, managed the regulatory approvals, screened participants for eligibility, scheduled virtual music therapy sessions, and interviewed participants. SB contributed to the design of the protocol and conducted qualitative analysis. KR served as a research assistant and administered the REDCap surveys. RR, MZ, and CT served as physician co-investigators, conducted review of any adverse events, and contributed to the design of the protocol. SRM served as the Principal Investigator. SRM conceived of the study, contributed to the development and design of the protocol, recruited participants, monitored the music therapy intervention, developed the REDCap database, conducted quantitative and qualitative analysis, and helped to draft the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
This study was conducted in accordance with the Declaration of Helsinki. This study was approved by the University Hospitals Cleveland Medical Center Institutional Review Board on October 10, 2023; IRB number: STUDY20230897. Written informed consent was obtained from all study participants.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Yu, H., Foss, A., Segall, T.L. et al. Refining a hybrid music therapy intervention for chronic obstructive pulmonary disease and heart failure: a single arm pilot study. BMC Complement Med Ther 25, 139 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12906-025-04887-x
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12906-025-04887-x